Scope:
The ACNP Records constitute 76 linear feet (51 archival cartons). They were originally deposited at Vanderbilt University between 1997 and 2008 and transferred to the UCLA Center for the Study of the History of Neuropsychopharmacology in 2008. There are no restrictions on use; however, copyright is retained by individual authors, as stipulated by copyright law. The papers include Council agendas, minutes, and correspondence; Committee and Task Force records and reports; correspondence and records from ACNP Presidents, Directors, and Secretaries, membership and Annual Meeting records, drafts of ACNP publications, videotaped oral histories and photographs.
ACNP FDA Task Force on Anti-Anxiety and Anti-Depressant Drugs 1972-74:
ACNP-FDA Task Force Notes
Guze Selection of Patients
ACNP-FDA Task Force Committee on Evaluating Antidepressant Drugs Minutes Sept 1972
Wittenborn Letter Nov 1972 to ACNP FDA Guideline Task Force Participants
Klerman-Wittenborn Letter Feb 1973
ACNP Task Force Proposal to FDA 1972
Uhlenhuth memo to Antianxiety Agents Guidelines Subcommittee Feb 1973
Guidelines Chapter I by W. R. Wittenborn
Guidelines Chapter II by W. R. Wittenborn
Guidelines Chapter III by Gerald Klerman
Guidelines Chapter IV by E. H. Uhlenhuth
ACNP Presidential Correspondence 1973-82 :
Wittenborn-DiMascio Letter 1973
Leonard Cook Correspondence 1982